tiprankstipranks
ASLAN Pharmaceuticals Faces Nasdaq Delisting
PremiumCompany AnnouncementsASLAN Pharmaceuticals Faces Nasdaq Delisting
6M ago
Aslan Pharmaceuticals receives Nasdaq delisting determination, will not appeal
Premium
The Fly
Aslan Pharmaceuticals receives Nasdaq delisting determination, will not appeal
6M ago
ASLAN Pharmaceuticals trading halted, news pending
Premium
The Fly
ASLAN Pharmaceuticals trading halted, news pending
7M ago
Aslan Pharmaceuticals presents data on eblasakimab as ATS conference
PremiumThe FlyAslan Pharmaceuticals presents data on eblasakimab as ATS conference
8M ago
ASLAN Pharmaceuticals Excels in Eblasakimab Trials
Premium
Company Announcements
ASLAN Pharmaceuticals Excels in Eblasakimab Trials
9M ago
Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year
Premium
The Fly
Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year
9M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
9M ago
Aslan Pharmaceuticals’ Eblasakimab Shows Promise
Premium
Company Announcements
Aslan Pharmaceuticals’ Eblasakimab Shows Promise
9M ago
Aslan announces interim results from Phase 2 study of eblasakimab
Premium
The Fly
Aslan announces interim results from Phase 2 study of eblasakimab
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100